ST
Sonali Thorat
Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, Rashtrasant Tukadoji Maharaj Nagpur University, Institute of Science Nagpur, B C Y R C's Institute of Pharmacy
Employment
-
Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune Visiting Professor2021 - Present
-
Rashtrasant Tukadoji Maharaj Nagpur University Contributory Lecturer2015 - 2018
-
B C Y R C's Institute of Pharmacy Lecturer2008 - 2010
Education
-
Rashtrasant Tukadoji Maharaj Nagpur University PhD2014 - 2019
-
Institute of Science Nagpur Post Graduate Diploma in Forensic Science2013 - 2014
-
Guru Nanak College of Pharmacy M. Pharm2010 - 2012
-
S. K. B College of Pharmacy, R T M Nagpur University B. Pharm2005 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (10)
- Design, synthesis, molecular modelling and antiproliferative evaluation of novel benzothiazole trihybrids Save
- Development and Validation of HPLC and HPTLC Methods for Therapeutic Drug Monitoring of Capecitabine in Colorectal Cancer Patients Save
- A Validated Stability-Indicating HPTLC Method for the Estimation of Capecitabine in its Tablet Dosage Form Save
- Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors Save
- A rapid and simple HPTLC assay for therapeutic drug monitoring of capecitabine in colorectal cancer patients Save
- A validated stability-indicating high-performance thin-layer chromatographic method for the analysis of methotrexate in bulk drug and marketed injection Save
- Determination and Pharmacokinetic Study of Pirfenidone in Rat Serum by High-Performance Thin-Layer Chromatography Save
- Development and validation of simple, rapid and sensitive UV, HPLC and HPTLC methods for the estimation of pirfenidone in tablet dosage form Save
- A validated stability-indicating high-performance thin-layer chromatographic method for the estimation of pirfenidone in tablet formulation Save
- Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers Save